AstraZeneca plans to build a US$1.5 billion manufacturing facility in Singapore to produce a promising category of cancer-killing drugs called antibody-drug conjugates (ADCs), the Anglo-Swedish drug maker said on Monday. …
Some heavyweight global investors may have timed their purchase of Chinese blue chips to perfection in the first quarter as the stock market gained momentum, while others may have missed …
AstraZeneca says it is withdrawing Vaxzevria, its vaccine to protect against COVID-19, from global markets. The vaccine was used early on in the pandemic in many countries, including Canada. In an …
AstraZeneca, a British-Swedish pharmaceutical and biotechnology company, has announced that it is withdrawing its COVID-19 vaccine, Vaxzevria, worldwide. According to the multinational pharmaceutical company, the vaccine is being withdrawn because …
We should be asking much deeper questions now than simply about whether and when another stock market bubble burst might come. We should be re-examining the role of private and …
AstraZeneca, Novartis and three other global drug makers have agreed to buy renewable energy from a Chinese supplier to run their manufacturing facilities on the mainland, helping to stem worsening …
Health Minister Mark Holland signalled Tuesday the government is unlikely to meet the end-of-the-year deadline imposed by the NDP for passing pharmacare legislation — a condition of the supply-and-confidence agreement …
The world is moving toward a more sustainable future, but the need for action and transformative leadership has never been more urgent. Forbes will bring together business leaders, entrepreneurs, policy …